In order to address whether the AhR pathway has a role in human skin pathology, we investigated whether AhR activation via the agonist FICZ or inhibition via the antagonist CH-223191 (Kim et al., 2006) would cause transcriptional changes in psoriasis-related genes. This evidence concerns the gene AHR and psoriasis.